Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial

PURPOSE: PERFORM is exploring the efficacy of terutroban versus aspirin for secondary prevention in patients with a history of ischemic stroke or transient ischemic attacks (TIAs). The PERFORM Vascular Project will evaluate the effect of terutroban on progression of atherosclerosis, as assessed by c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennerici, Michael G., Bots, Michiel L., Ford, Ian, Laurent, Stéphane, Touboul, Pierre Jean
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887499/
https://www.ncbi.nlm.nih.gov/pubmed/20490906
http://dx.doi.org/10.1007/s10557-010-6231-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887499/
https://www.ncbi.nlm.nih.gov/pubmed/20490906
http://dx.doi.org/10.1007/s10557-010-6231-2

Ejemplares similares